Budecort Inhaler 200 MD 100 mcg Cipla

All about product
Specification
Reviews
0
Questions
0
Out Of Stock
Budecort Inhaler 200 MD 100 mcg Cipla
Budecort Inhaler 200 MD 100 mcg Cipla Budecort Inhaler 200 MD 100 mcg Cipla Budecort Inhaler 200 MD 100 mcg Cipla Budecort Inhaler 200 MD 100 mcg Cipla Budecort Inhaler 200 MD 100 mcg Cipla
Product Code: EU14183
Brand: Cipla
Reviews: 0
27.00€
Specifications: (See all)
Active substance
Budesonide
Also known as
Budesonidum
Blood pressure
Typically no effect on blood pressure
Chemical name
(RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
Dosage (medical)
Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day)
Description

Budecort Inhaler 200 MD 100 mcg Cipla role in sports pharmacology

The Budecort Inhaler 200 MD 100 mcg Cipla is a significant preparation in the realm of sports pharmacology, primarily recognized for its efficacy in managing respiratory conditions. This inhaler contains Budesonide, a corticosteroid that plays a critical role in reducing inflammation in the lungs, making it particularly useful for athletes suffering from asthma or other chronic obstructive pulmonary diseases. Athletes often face challenges associated with respiratory issues that can hinder their performance. The Budecort Inhaler is designed to target inflammation directly and provide relief from respiratory distress. Its primary purpose is to deliver a measured dose of medication directly to the lungs, facilitating easier breathing and allowing athletes to maintain their performance levels. For many sports enthusiasts, particularly those engaging in high-intensity activities or endurance sports, effective management of asthma symptoms is essential for achieving peak performance. Given its relevance, Budecort Inhaler has gained popularity among athletes in competitive sports who seek to ensure their respiratory function is optimized while adhering to safety and regulatory practices. It is crucial to understand both the potential benefits and limitations of this inhaler to utilize it effectively in both training and competition settings.

Dosage scheme and optimal use

When prescribing the Budecort Inhaler, a healthcare professional will typically determine the appropriate dosage scheme based on the individual needs of the user. The standard recommended dosage for adults and children aged six years and above is generally one or two puffs twice daily, which can be adjusted depending on the severity of the individual's condition. For optimal use, the inhaler should be used correctly to ensure that the medication is effectively delivered to the lungs. Here are steps to enhance the administration of the inhaler: 1. Shake the inhaler well before each use. 2. Breathe out completely to empty the lungs. 3. Place the mouthpiece in your mouth and close your lips around it. 4. While breathing in deeply and slowly, press down on the inhaler to release a dose. 5. Hold your breath for ten seconds to allow the medication to settle in the lungs. 6. Wait for about one minute before taking the second puff, if prescribed. Regular use, even when symptoms are not present, is crucial for effective asthma management. Patients should consult with their healthcare provider about adjusting their dosage based on their specific needs and the intensity of their symptoms.

Main benefits of Budecort Inhaler 200 MD 100 mcg Cipla

The Budecort Inhaler is recognized for several key advantages, making it a preferred choice among those dealing with respiratory conditions. Its benefits are transformed into improved quality of life, enabling both athletes and daily users to breathe easier. Here are some highlighted core benefits:
  • Effective management of asthma symptoms.
  • Reduces inflammation in the airways.
  • Enhances lung function over time.
  • Quick relief during asthma attacks when used as directed.
  • Convenient and portable inhalation method.
These benefits contribute to both immediate and long-term improvements in respiratory health. Athletes using Budecort Inhaler can maintain higher performance levels and engage in more vigorous training sessions without being hindered by their respiratory issues. Furthermore, Budecort is less likely to lead to significant side effects compared to systemic corticosteroids, making it safer for long-term use.

Contraindications and important limitations of use

While Budecort Inhaler 200 MD 100 mcg Cipla offers significant benefits, it is important to recognize certain contraindications and limitations to ensure the safety of its use. Individuals with known hypersensitivity to Budesonide or any of its components should avoid using this inhaler. Additionally, those suffering from systemic fungal infections or tuberculosis should not use it, as corticosteroids can compromise the immune system. Patients with uncontrolled hypertension, certain cardiovascular conditions, and those recently recovering from surgery or illness should consult their healthcare provider before initiating treatment with this inhaler. Pregnant or breastfeeding women should also discuss the potential risks and benefits with their doctor, as corticosteroid use during these times must be approached with caution. In conclusion, while the Budecort Inhaler provides remarkable benefits for managing respiratory conditions among athletes and non-athletes alike, understanding its application, dosage, and contraindications is crucial for safe and effective use. Always consult with a healthcare professional to tailor the approach to individual health needs and conditions.
Specifications
Features
Active substance
Budesonide
Also known as
Budesonidum
Blood pressure
Typically no effect on blood pressure
Chemical name
(RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
Dosage (medical)
Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day)
Dosage (sports)
Not applicable
Effects
Reduces inflammation, suppresses immune response
Formula
C25H34O6
Half-life
2 to 3.6 hours
Hepatotoxicity
Low
Lab Test
Not specific for standard drug tests
Main action
Anti-inflammatory
Side effects
Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression
Storage conditions
Store in a cool, dry place away from direct sunlight
Strength
100mcg
Substance class
Corticosteroid
Trade name
Pulmicort, Rhinocort
Use in sports
Not commonly used, except for legitimate asthma treatment
Water Retention
Minimal
Manufacturer
Cipla Ltd.
Packing
1 Inhaler/pack
Reviews
0 / 5
average product rating
0
0
0
0
0

There are no reviews for this product, be the first to leave your review.

Answers & questions

No questions about this product, be the first and ask your question.

Budecort Inhaler 200 MD 100 mcg Cipla
27.00€